effects [qlco]
Conjugated Equine Estrogens [horm, phsu, strd]
Raloxifene [orch, phsu]
Lipid [lipd]
Profile [lbpr]
Coagulation [ortf]
Fibrinolysis [phsf]
postmenopausal [tmco]
Women [popg]
objectives [inpr]
Conjugated Equine Estrogens [horm, phsu, strd]
Raloxifene [orch, phsu]
Lipid [lipd]
Profile [lbpr]
Haemostasis [ortf]
Materials [sbst]
Methods [inpr]
DOUBLE BLIND [resa]
randomized [resa]
Parallel Study [resa]
Performed [ftcn]
>90 [qnco]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Aged [orga]
divided [ftcn]
Group [idcn]
Submitted [ftcn]
Daily [tmco]
therapy [ftcn]
Conjugated Equine Estrogens [horm, phsu, strd]
mg% [qnco]
Raloxifene 60 MG [clnd]
placebo [topp]
months [tmco]
Lipid [lipd]
Profile [lbpr]
Coagulation [ortf]
fibrinolytic [topp]
Conjugated Equine Estrogens [horm, phsu, strd]
Increased [qnco]
Levels [qlco]
High Density Lipoprotein Cholesterol [bacs, lipd]
mg dl [qnco]
P NOS [aapp, imft]
Very low density lipoprotein cholesterol [bacs, strd]
mg dl [qnco]
P NOS [aapp, imft]
Triglycerides [bacs, lipd]
mg dl [qnco]
P NOS [aapp, imft]
Decreased [qnco]
Levels [qlco]
Low Density Lipoprotein Cholesterol [bacs, strd]
mg dl [qnco]
P NOS [aapp, imft]
Raloxifene [orch, phsu]
Levels [qlco]
High Density Lipoprotein Cholesterol [bacs, lipd]
mg dl [qnco]
P NOS [aapp, imft]
reduction [npop]
Low Density Lipoprotein Cholesterol [bacs, strd]
mg dl [qnco]
P NOS [aapp, imft]
Very low density lipoprotein cholesterol [bacs, strd]
mg dl [qnco]
P NOS [aapp, imft]
Triglycerides [bacs, lipd]
mg dl [qnco]
P NOS [aapp, imft]
Conjugated Equine Estrogens [horm, phsu, strd]
Decreased [qnco]
Levels [qlco]
Fibrinogen [aapp, bacs, phsu]
g l [qnco]
P NOS [aapp, imft]
Levels [qlco]
Antithrombin III [aapp, phsu]
P NOS [aapp, imft]
Raloxifene [orch, phsu]
Decreased [qnco]
Levels [qlco]
Fibrinogen [aapp, bacs, phsu]
g l [qnco]
P NOS [aapp, imft]
Levels [qlco]
Antithrombin III [aapp, phsu]
P NOS [aapp, imft]
Conjugated Equine Estrogens [horm, phsu, strd]
Increased [qnco]
Levels [qlco]
Protein C [aapp, bacs, phsu]
mg/L [qnco]
P NOS [aapp, imft]
Raloxifene [orch, phsu]
Levels [qlco]
Protein C [aapp, bacs, phsu]
mg/L [qnco]
P NOS [aapp, imft]
Conjugated Equine Estrogens [horm, phsu, strd]
Decreased [qnco]
antigen levels [lbpr]
Tissue Plasminogen Activator [aapp, enzy, phsu]
U/ml [qnco]
P NOS [aapp, imft]
Plasminogen activator inhibitor [aapp, bacs]
U/ml [qnco]
P NOS [aapp, imft]
0.010" [qnco]
Raloxifene [orch, phsu]
Tissue Plasminogen Activator [aapp, enzy, phsu]
U/ml [qnco]
P NOS [aapp, imft]
Plasminogen activator inhibitor antigen [imft]
U/ml [qnco]
P NOS [aapp, imft]
